Literature DB >> 17994651

Studies on 1,2,4-triazole derivatives as potential anti-inflammatory agents.

Gülhan Turan-Zitouni1, Zafer Asim Kaplancikli, Ahmet Ozdemir, Pierre Chevallet, Hilmi Burak Kandilci, Bülent Gümüsel.   

Abstract

The reaction of acetic or propionic acid hydrazides with various aryl/alkyl isothiocyanates gave thiosemicarbazides which furnished the 1,2,4-triazoles by alkali cyclization. The 4-aryl/alkyl-5-(1-phenoxyethyl)-3-[N-(substituted)acetamido]thio-4H-1,2,4-triazole derivatives were synthesized by reacting the triazoles with 2-chloro-N-(substituted)acetamide. The chemical structures of the compounds were elucidated by IR, (1)H-NMR, FAB(+)-MS spectral data and elemental analysis. In the pharmacological studies, anti-inflammatory activities of these compounds have been screened and significant activities were observed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17994651     DOI: 10.1002/ardp.200700134

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  10 in total

1.  Parallel synthesis of 1,2,4-triazole derivatives using microwave and continuous-flow techniques.

Authors:  Tamás Szommer; András Lukács; József Kovács; Miklós J Szabó; Michael G Hoffmann; Monika H Schmitt; János Gerencsér
Journal:  Mol Divers       Date:  2012-01-26       Impact factor: 2.943

2.  A facile iodine(III)-mediated synthesis of 3-(3-aryl-1-phenyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridines via oxidation of 2-((3-aryl-1-phenyl-1H-pyrazol-4-yl)methylene)-1-(pyridin-2-yl)hydrazines and their antimicrobial evaluations.

Authors:  Om Prakash; Khalid Hussain; Deepak K Aneja; Chetan Sharma; Kamal R Aneja
Journal:  Org Med Chem Lett       Date:  2011-07-18

3.  Synthesis and antimicrobial evaluation of ester-linked 1,4-disubstituted 1,2,3-triazoles with a furyl/thienyl moiety.

Authors:  C P Kaushik; Raj Luxmi; Dharmendra Singh; Ashwani Kumar
Journal:  Mol Divers       Date:  2016-11-29       Impact factor: 2.943

4.  N-Pyrazoloyl and N-thiopheneacetyl hydrazone of isatin exhibited potent anti-inflammatory and anti-nociceptive properties through suppression of NF-κB, MAPK and oxidative stress signaling in animal models of inflammation.

Authors:  Sara Zeeshan; Muhammad Naveed; Adnan Khan; Ayesha Atiq; Maryam Arif; Muhammad Naeem Ahmed; Yeong Shik Kim; Salman Khan
Journal:  Inflamm Res       Date:  2019-05-11       Impact factor: 4.575

5.  Synthesis of 2-(N-Benzylpyrrolyl)-benzimidazoles Using Polyphosphoric Acid Prompted Cyclocondensation.

Authors:  Bereket Mochona; Laine Le; Madhavi Gangapuram; Nelly Mateeva; Tiffany Ardley; Kinfe K Redda
Journal:  J Heterocycl Chem       Date:  2010-11-01       Impact factor: 2.193

6.  Synthesis, Characterization, and BSA Binding Studies of Some New Benzamides Related to Schiff Base.

Authors:  M K Prashanth; M Madaiah; H D Revanasiddappa; K N Amruthesh
Journal:  ISRN Org Chem       Date:  2013-04-07

7.  2,2'-[Naphthalene-1,5-diylbis(nitrilo-methanylyl-idene)]diphenol.

Authors:  S Karthikeyan; J Muthukumaran; R Krishna; Bala Manimaran
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-22

8.  The synthesis of a Cu(ii) Schiff base complex using a bidentate N2O2 donor ligand: crystal structure, photophysical properties, and antibacterial activities.

Authors:  Yaning Guo; Xiaobing Hu; Xinli Zhang; Xiaohua Pu; Yue Wang
Journal:  RSC Adv       Date:  2019-12-17       Impact factor: 3.361

9.  Synthesis of Schiff and Mannich bases of isatin derivatives with 4-amino-4,5-dihydro-1H-1,2,4-triazole-5-ones.

Authors:  Olcay Bekircan; Hakan Bektas
Journal:  Molecules       Date:  2008-09-10       Impact factor: 4.411

10.  Synthesis of Novel 2,5-Disubstituted-1,3,4-thiadiazoles Clubbed 1,2,4-Triazole, 1,3,4-Thiadiazole, 1,3,4-Oxadiazole and/or Schiff Base as Potential Antimicrobial and Antiproliferative Agents.

Authors:  Nadjet Rezki; Amjad M Al-Yahyawi; Sanaa K Bardaweel; Fawzia F Al-Blewi; Mohamed R Aouad
Journal:  Molecules       Date:  2015-09-02       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.